Gene Research
Gene clusters provide a means for detecting and managing prostate cancer
Published in Gene Therapy Weekly, July 14th, 2005
According to a study from the Netherlands, "the vast majority of androgen-dependent prostate tumors progress coward incurable, androgen-independent tumors. The identification of androgen-responsive genes, which are still actively transcribed in the tumors of patients who have undergone androgen ablation, may shed light on the molecular mechanisms underlying this phenomenon."
"To address this question, we chose the Dunning R3327 rat model system, in which the progression from androgen-dependent to -independent tumors is represented by several transplantable prostate-derived...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-07-14)
More Articles from Gene Therapy Weekly
- Brain Cancer
Interleukin-2 gene delivery sends glioblastoma into remission in rats - Drug Research
Antisense oligomer AVI-4126 has bioavailability in malignant tumors - Neurology
Angiogenic gene therapy diminishes cisplatin-induced peripheral neuropathy - Spinal Cord Injury
Poliovirus replicons encoding interleukin-10 encourage spinal cord recovery - Urology
Promyelocytic leukemia cDNA stifles bladder cancer cell growth - Allergy and Immunology
Heat shock protein 70 propels gene-directed enzyme prodrug therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
